OnOctober 12, at the 2026 OCP Global Summit, Lenovo Group announced that it has begun global deliveries of NVIDIA's next-generation Vera Rubin NVL72 rack-scal ...
On the afternoon of July 18, Lei Jun, the founder of Xiaomi Technology Co., Ltd., announced that the "Xiaomi Shenzhen Building," located by the Shenzhen Bay, officially opened today. At the same time, ...
Goldman Sachs: Microsoft’s AI investment enters a new phase, with market focus shifting to returns
1. Goldman Sachs projects that Microsoft's Azure revenue growth rate may reach 46%–47% in the first quarter of fiscal year 2027; 2. Microsoft's capital expenditure for fiscal year 2027 is expected to ...
10-K:Micron Technology | 10-K: FY2025 Annual Report Google's Q3 results fell short of expectations, with free cash flow plunging and growing skepticism over the return on its AI investments. Google ...
MainpointsThe acceleration in hardware spending is driven primarily by cyclical factors rather than structural demand from AI. By 2027, hardware expenditures ...
10-K:NVIDIA | 10-K: FY2025 Annual Report Bloomberg: South Korea's stock market has become the first trillion-dollar market to fall below a price-to-earnings ratio of 5. Trump threatened to launch a ...
10-K:Duolingo | 10-K: FY2024 Annual Report Weekly Outlook | The Federal Reserve's decision, along with U.S. GDP and core PCE, are set to make a big splash! Google, Microsoft, and Amazon will release ...
â‘ The core question the market most urgently seeks to answer is: Who will be the 'next supply bottleneck' in the AI supply chain? â‘¡ Goldman Sachs believes the answer may lie in an unassuming and ...
MainpointsPost-election asset rallies in Brazil reflect optimism about fiscal reform, yet the path to debt sustainability remains fraught with challenges. The ...
ByAl Root SpaceX upended the wireless communications industry this past week by purchasing low-band spectrum. The ripple effects of that move are still being ...
Continuedpurchases and organic accumulation drive approximately 12% growth in SOL holdings since the Company's August 12 Earnings Update CHAD offers a 13% ann ...
Gan& Lee Pharmaceuticals (SHA:603087) said its GLR1075 injection completed the first subject dosing in phase one clinical trials in China.GLR1075 is intended ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results